# Adalimumab

NDC: 61314-325
Generic name: adalimumab-adaz
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250106

FDA application: BLA761071

## Active ingredients

- ADALIMUMAB: 80 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-325"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-325
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3468792f-63ef-4916-8ed1-8214f327d9dd